Stefano Papi

689 total citations
25 papers, 446 citations indexed

About

Stefano Papi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Stefano Papi has authored 25 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Stefano Papi's work include Radiopharmaceutical Chemistry and Applications (10 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Stefano Papi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Neuroendocrine Tumor Research Advances (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Stefano Papi collaborates with scholars based in Italy, United States and Switzerland. Stefano Papi's co-authors include Giovanni Paganelli, Marco Chinol, Chiara Maria Grana, Mirco Bartolomei, Lisa Bodei, Marta Cremonesi, M. Fiorenza, Mauro Ginanneschi, Marzia Colandrea and Nicola Fazio and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Stefano Papi

25 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefano Papi Italy	10	193	182	179	146	60	25	446
Chiara Grana Italy	7	318 1.6×	281 1.5×	283 1.6×	206 1.4×	50 0.8×	8	696
Gregor J. Förster Germany	11	83 0.4×	270 1.5×	56 0.3×	53 0.4×	78 1.3×	18	482
John G. Wolbers Netherlands	10	90 0.5×	129 0.7×	170 0.9×	134 0.9×	11 0.2×	13	471
Thomas Buettner Germany	12	89 0.5×	202 1.1×	69 0.4×	34 0.2×	17 0.3×	13	462
Anne Gruaz‐Guyon France	17	214 1.1×	486 2.7×	142 0.8×	24 0.2×	58 1.0×	28	752
Atsushi Doi Japan	12	118 0.6×	337 1.9×	45 0.3×	42 0.3×	41 0.7×	18	657
Thomas Pangerl Austria	11	220 1.1×	162 0.9×	284 1.6×	141 1.0×	29 0.5×	14	446
J. M. Reno United States	7	150 0.8×	501 2.8×	44 0.2×	25 0.2×	67 1.1×	9	645
Arthur van Gameren Netherlands	11	380 2.0×	435 2.4×	447 2.5×	211 1.4×	11 0.2×	14	711
Abram Vaccaro United States	8	172 0.9×	38 0.2×	114 0.6×	70 0.5×	19 0.3×	14	523

Countries citing papers authored by Stefano Papi

Since Specialization

Citations

This map shows the geographic impact of Stefano Papi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Papi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Papi more than expected).

Fields of papers citing papers by Stefano Papi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Papi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Papi. The network helps show where Stefano Papi may publish in the future.

Co-authorship network of co-authors of Stefano Papi

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Papi. A scholar is included among the top collaborators of Stefano Papi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Papi. Stefano Papi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dia, A. Di, Mahila Ferrari, Laura Lavinia Travaini, et al.. (2025). The value of dosimetry in Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors: literature and practical aspects. Clinical and Translational Imaging. 13(2). 121–129. 1 indexed citations

Rubino, Manila, Lisa Bodei, Stefano Papi, et al.. (2024). Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis. Endocrine. 84(2). 704–710. 4 indexed citations

Buonomo, Oreste Claudio, Gianluca Vanni, Marco Materazzo, et al.. (2023). Telehealth in oncofertility and breast cancer patients during COVID-19: preliminary results of insenoallasalute.it project.. PubMed. 27(11). 5327–5337. 2 indexed citations

Bertani, Emilio, F. Collamati, Marzia Colandrea, et al.. (2021). First Ex Vivo Results of β ⁻ -Radioguided Surgery in Small Intestine Neuroendocrine Tumors with ⁹⁰ Y-DOTATOC. Cancer Biotherapy and Radiopharmaceuticals. 36(5). 397–406. 7 indexed citations

Morganti, S., Emilio Bertani, V. Bocci, et al.. (2020). Tumor-non-tumor discrimination by a β - detector for Radio Guided Surgery on ex-vivo neuroendocrine tumors samples. Physica Medica. 72. 96–102. 10 indexed citations

Papi, Stefano, et al.. (2019). State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging. Current Radiopharmaceuticals. 12(2). 107–125. 6 indexed citations

Mariniello, Annapaola, Lisa Bodei, Carmine Tinelli, et al.. (2015). Long-term results of PRRT in advanced bronchopulmonary carcinoid. European Journal of Nuclear Medicine and Molecular Imaging. 43(3). 441–452. 88 indexed citations

Papi, Stefano, et al.. (2015). Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience. Current Radiopharmaceuticals. 9(1). 19–32. 4 indexed citations

Papi, Stefano, et al.. (2010). Testing of microbial contamination during the preparation of the radiocompound [⁹⁰Y]DOTATOC for clinical trials: a process validation study by Media Fill approach.. PubMed. 54(5). 553–9. 5 indexed citations

10.

Papi, Stefano, Annalisa Rossi, Marta Cremonesi, et al.. (2009). Radiolabeling optimization and reduced staff radiation exposure for high-dose 90Y-ibritumomab tiuxetan (HD-Zevalin). Nuclear Medicine and Biology. 37(1). 85–93. 5 indexed citations

11.

Corbucci, G., et al.. (2008). Long-term follow-up of patients paced in VDD mode for advanced atrioventricular block: a pilot study. Journal of Cardiovascular Medicine. 9(1). 39–42. 7 indexed citations

12.

Vanazzi, Anna, Daniele Laszlò, Marta Cremonesi, et al.. (2008). Red Marrow Dosimetry and Stem Cell Reinfusion in High Dose 90Y - Ibritumomab Tiuxetan.. Blood. 112(11). 2187–2187. 1 indexed citations

13.

Cremonesi, Marta, Mahila Ferrari, Chiara Maria Grana, et al.. (2007). High-Dose Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan: Comparative Dosimetric Study for Tailored Treatment. Journal of Nuclear Medicine. 48(11). 1871–1879. 36 indexed citations

14.

Ferrucci, Pier Francesco, Anna Vanazzi, Chiara Maria Grana, et al.. (2007). High activity ⁹⁰Y‐ibritumomab tiuxetan (Zevalin^®) with peripheral blood progenitor cells support in patients with refractory/resistant B‐cell non‐Hodgkin lymphomas. British Journal of Haematology. 139(4). 590–599. 33 indexed citations

15.

Vanazzi, Anna, Pier Francesco Ferrucci, Chiara Maria Grana, et al.. (2007). High Dose 90Yttrium Ibritumomab Tiuxetan with PBSC Support in Refractory-Resistant NHL Patients.. Blood. 110(11). 1890–1890. 1 indexed citations

16.

Urbano, Nicoletta, Stefano Papi, Mauro Ginanneschi, et al.. (2006). Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT®). European Journal of Nuclear Medicine and Molecular Imaging. 34(1). 68–77. 40 indexed citations

17.

Vanazzi, Anna, Pier Francesco Ferrucci, Chiara Maria Grana, et al.. (2006). High dose ⁹⁰Yttrium ibritumomab tiuxetan with PBSC support in refractory-resistant NHL patients: Preliminary results of a phase I/II study. Journal of Clinical Oncology. 24(18_suppl). 7587–7587. 4 indexed citations

18.

Chinol, Marco, Ottavio De Cobelli, Giuseppe Trifirò, et al.. (2003). Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy. European Urology. 44(5). 556–559. 16 indexed citations

19.

Chini, Bice, Marco Chinol, Paola Cassoni, et al.. (2003). Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue. British Journal of Cancer. 89(5). 930–936. 25 indexed citations

20.

Paganelli, Giovanni, Lisa Bodei, Daria Handkiewicz-Junak, et al.. (2002). ⁹⁰Y–DOTA–D‐Phe¹–Try³– octreotide in therapy of neuroendocrine malignancies. Biopolymers. 66(6). 393–398. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact